browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
908d22a6-f451-4151-ba8f-2ba2e10cf81b
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 22:17:27
Income (reported)
$50,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

AVENUE SOLUTIONS

Government representation

Contact
AMY TEJRAL
Phone
+1 202-347-9848
Address
zip:20004, city:Washington, state:DC, street:401 9th St. NW Suite 720
Client

JAZZ PHARMACEUTICALS, INC.

Specialty pharmaceuticals

State
CA
Country
US
Government-entity client
false
Effective date
2012-03-01
Issues lobbied + lobbyists (2)

HCR — Health Issues

Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing, including orphan drugs; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to implementation of the Inflation Reduction Act of 2022

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.